Live Breaking News & Updates on E Opgn Us68373l4068

Stay updated with breaking news from E opgn us68373l4068. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March. | March 29, 2023 ....

Curetis Gmb , Oliver Schacht , Albert Weber , Gene Panel , International Number , Foundation For Innovative New Diagnostics , European Investment Bank , Securities Exchange , Opgen Investor Press Contact , Technology Platform , Opgen Inc , Exchange Commission , Edison Group , Full Year , Chief Financial Officer , Beijing Clear Biotech , Ares Genetics , Innovative New Diagnostics , Dial In Number , United Statesa , Curetis Gmbh , Ares Genetics Gmbh , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Capital Market ,